Quantinno Capital Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.33M Sell
459,429
-382,663
-45% -$4.2M 0.01% 1203
2025
Q4
$10.5M Buy
842,092
+601,738
+250% +$8M 0.02% 763
2025
Q3
$3.44M Buy
240,354
+162,922
+210% +$2.23M 0.01% 1049
2025
Q2
$950K Sell
77,432
-90,888
-54% -$1.32M ﹤0.01% 1338
2025
Q1
$3.7M Buy
168,320
+118,972
+241% +$2.8M 0.02% 779
2024
Q4
$1.12M Buy
+49,348
New +$1.08M 0.01% 1021
2024
Q3
Sell
-46,689
Closed -$1.36M 1479
2024
Q2
$1.36M Buy
46,689
+19,864
+74% +$589K 0.02% 709
2024
Q1
$951K Sell
26,825
-5,519
-17% -$221K 0.02% 752
2023
Q4
$1.41M Buy
32,344
+19,954
+161% +$785K 0.05% 509
2023
Q3
$473K Buy
+12,390
New +$521K 0.02% 738
2023
Q2
Sell
-19,081
Closed -$1.09M 928
2023
Q1
$1.09M Buy
+19,081
New +$1.08M 0.07% 354
2022
Q3
Sell
-10,390
Closed -$561K 633
2022
Q2
$561K Buy
10,390
+3,616
+53% +$217K 0.08% 311
2022
Q1
$435K Buy
+6,774
New +$446K 0.07% 334
2021
Q4
Sell
-5,176
Closed -$354K 521
2021
Q3
$354K Buy
5,176
+88
+2% +$6.22K 0.4% 110
2021
Q2
$347K Hold
5,088
0.39% 120
2021
Q1
$352K Sell
5,088
-837
-14% -$56.7K 0.38% 116
2020
Q4
$385K Buy
+5,925
New +$319K 0.3% 157
2020
Q2
Sell
-8,732
Closed -$390K 373
2020
Q1
$390K Buy
+8,732
New +$458K 0.24% 210
2019
Q4
Sell
-5,513
Closed -$331K 443
2019
Q3
$331K Hold
5,513
0.22% 228
2019
Q2
$308K Buy
+5,513
New +$284K 0.18% 276

Other funds holding IART

Quantinno Capital Management's IART Position: Q1 2026 in Review

Quantinno Capital Management reduced its Integra LifeSciences (IART) stake by 45% in Q1 2026, selling an estimated $4.2M and leaving 459,429 shares worth $4.33M. The position accounts for 0.01% of the portfolio, ranked #1203.

Quantinno Capital Management first reported a position in IART in Q2 2019 and has held it in 20 quarters since. The position peaked at $10.5M in Q4 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Quantinno Capital Management held 459,429 shares of Integra LifeSciences worth $4.33M as of Q1 2026.
  • Quantinno Capital Management sold 382,663 Integra LifeSciences shares in Q1 2026, an estimated $4.2M.
  • Integra LifeSciences made up 0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #1203 holding.
  • Quantinno Capital Management first reported a position in Integra LifeSciences in Q2 2019 and has held it in 20 quarters since.
  • Quantinno Capital Management's Integra LifeSciences position peaked at $10.5M in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.